ICU Medical, Inc. (NASDAQ: ICUI) Stock Competitors & Peer Comparison
See ICUI's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for ICUI and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ICUI | $158.15 | +0.35% | 3.9B | 19.46 | $8.01 | N/A |
| ISRG | $385.13 | +1.90% | 133.2B | 39.21 | $9.62 | N/A |
| BDXA | $59.24 | -2.24% | 55.9B | 45.70 | $1.30 | +2.13% |
| BDX | $184.20 | +0.71% | 51.2B | 14.30 | $13.00 | +2.13% |
| RMD | $227.67 | +2.10% | 33.3B | 21.32 | $10.77 | +1.06% |
| MDLN | $33.50 | +2.78% | 27.2B | 23.53 | $1.36 | N/A |
| WST | $361.98 | +1.91% | 25.7B | 42.93 | $8.50 | +0.24% |
| HOLX | $76.01 | +0.00% | 17B | 31.54 | $2.41 | N/A |
| SOLV | $90.53 | +0.79% | 15.6B | 12.69 | $7.10 | N/A |
| BDXB | $48.16 | +1.39% | 13.7B | 7.60 | $6.33 | +2.13% |
Stock Comparison
Intuitive Surgical, Inc. (NASDAQ: ISRG)
ICUI vs ISRG Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, ISRG has a market cap of 133.2B. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while ISRG trades at $385.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas ISRG's P/E ratio is 39.21. In terms of profitability, ICUI's ROE is +0.01%, compared to ISRG's ROE of +0.18%. Regarding short-term risk, ICUI is less volatile compared to ISRG. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check ISRG's competition here
Becton, Dickinson and Company (NYSE: BDXA)
ICUI vs BDXA Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, BDXA has a market cap of 55.9B. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while BDXA trades at $59.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas BDXA's P/E ratio is 45.70. In terms of profitability, ICUI's ROE is +0.01%, compared to BDXA's ROE of +0.04%. Regarding short-term risk, ICUI is less volatile compared to BDXA. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check BDXA's competition here
Becton, Dickinson and Company (NYSE: BDX)
ICUI vs BDX Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, BDX has a market cap of 51.2B. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while BDX trades at $184.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas BDX's P/E ratio is 14.30. In terms of profitability, ICUI's ROE is +0.01%, compared to BDX's ROE of +0.04%. Regarding short-term risk, ICUI is more volatile compared to BDX. This indicates higher risk in terms of short-term price fluctuations for ICUI.Check BDX's competition here
ResMed Inc. (NYSE: RMD)
ICUI vs RMD Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, RMD has a market cap of 33.3B. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while RMD trades at $227.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas RMD's P/E ratio is 21.32. In terms of profitability, ICUI's ROE is +0.01%, compared to RMD's ROE of +0.24%. Regarding short-term risk, ICUI is less volatile compared to RMD. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check RMD's competition here
Medline Inc. (NASDAQ: MDLN)
ICUI vs MDLN Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, MDLN has a market cap of 27.2B. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while MDLN trades at $33.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas MDLN's P/E ratio is 23.53. In terms of profitability, ICUI's ROE is +0.01%, compared to MDLN's ROE of +0.05%. Regarding short-term risk, ICUI is less volatile compared to MDLN. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check MDLN's competition here
West Pharmaceutical Services, Inc. (NYSE: WST)
ICUI vs WST Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, WST has a market cap of 25.7B. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while WST trades at $361.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas WST's P/E ratio is 42.93. In terms of profitability, ICUI's ROE is +0.01%, compared to WST's ROE of +0.19%. Regarding short-term risk, ICUI is less volatile compared to WST. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check WST's competition here
Hologic, Inc. (NASDAQ: HOLX)
ICUI vs HOLX Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, HOLX has a market cap of 17B. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while HOLX trades at $76.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas HOLX's P/E ratio is 31.54. In terms of profitability, ICUI's ROE is +0.01%, compared to HOLX's ROE of +0.11%. Regarding short-term risk, ICUI is more volatile compared to HOLX. This indicates higher risk in terms of short-term price fluctuations for ICUI.Check HOLX's competition here
Solventum Corporation (NYSE: SOLV)
ICUI vs SOLV Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, SOLV has a market cap of 15.6B. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while SOLV trades at $90.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas SOLV's P/E ratio is 12.69. In terms of profitability, ICUI's ROE is +0.01%, compared to SOLV's ROE of +0.29%. Regarding short-term risk, ICUI is less volatile compared to SOLV. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check SOLV's competition here
Becton, Dickinson and Company (NYSE: BDXB)
ICUI vs BDXB Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, BDXB has a market cap of 13.7B. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while BDXB trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas BDXB's P/E ratio is 7.60. In terms of profitability, ICUI's ROE is +0.01%, compared to BDXB's ROE of +0.04%. Regarding short-term risk, ICUI is less volatile compared to BDXB. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check BDXB's competition here
Baxter International Inc. (NYSE: BAX)
ICUI vs BAX Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, BAX has a market cap of 12.3B. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while BAX trades at $23.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas BAX's P/E ratio is 11.39. In terms of profitability, ICUI's ROE is +0.01%, compared to BAX's ROE of -0.17%. Regarding short-term risk, ICUI is less volatile compared to BAX. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check BAX's competition here
Avantor, Inc. (NYSE: AVTR)
ICUI vs AVTR Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, AVTR has a market cap of 10.4B. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while AVTR trades at $15.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas AVTR's P/E ratio is 18.15. In terms of profitability, ICUI's ROE is +0.01%, compared to AVTR's ROE of -0.10%. Regarding short-term risk, ICUI is less volatile compared to AVTR. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check AVTR's competition here
The Cooper Companies, Inc. (NASDAQ: COO)
ICUI vs COO Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, COO has a market cap of 10.4B. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while COO trades at $54.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas COO's P/E ratio is 11.68. In terms of profitability, ICUI's ROE is +0.01%, compared to COO's ROE of +0.07%. Regarding short-term risk, ICUI is less volatile compared to COO. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check COO's competition here
Repligen Corporation (NASDAQ: RGEN)
ICUI vs RGEN Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, RGEN has a market cap of 9.9B. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while RGEN trades at $174.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas RGEN's P/E ratio is 97.07. In terms of profitability, ICUI's ROE is +0.01%, compared to RGEN's ROE of +0.02%. Regarding short-term risk, ICUI is less volatile compared to RGEN. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check RGEN's competition here
AptarGroup, Inc. (NYSE: ATR)
ICUI vs ATR Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, ATR has a market cap of 8B. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while ATR trades at $125.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas ATR's P/E ratio is 21.79. In terms of profitability, ICUI's ROE is +0.01%, compared to ATR's ROE of +0.14%. Regarding short-term risk, ICUI is more volatile compared to ATR. This indicates higher risk in terms of short-term price fluctuations for ICUI.Check ATR's competition here
Bausch + Lomb Corporation (NYSE: BLCO)
ICUI vs BLCO Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, BLCO has a market cap of 6.2B. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while BLCO trades at $17.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas BLCO's P/E ratio is 26.52. In terms of profitability, ICUI's ROE is +0.01%, compared to BLCO's ROE of -0.03%. Regarding short-term risk, ICUI is more volatile compared to BLCO. This indicates higher risk in terms of short-term price fluctuations for ICUI.Check BLCO's competition here
Stevanato Group S.p.A. (NYSE: STVN)
ICUI vs STVN Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, STVN has a market cap of 5.9B. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while STVN trades at $21.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas STVN's P/E ratio is 32.57. In terms of profitability, ICUI's ROE is +0.01%, compared to STVN's ROE of +0.09%. Regarding short-term risk, ICUI is less volatile compared to STVN. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check STVN's competition here
Teleflex Incorporated (NYSE: TFX)
ICUI vs TFX Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, TFX has a market cap of 5.7B. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while TFX trades at $129.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas TFX's P/E ratio is 14.75. In terms of profitability, ICUI's ROE is +0.01%, compared to TFX's ROE of -0.32%. Regarding short-term risk, ICUI is less volatile compared to TFX. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check TFX's competition here
Merit Medical Systems, Inc. (NASDAQ: MMSI)
ICUI vs MMSI Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, MMSI has a market cap of 5.1B. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while MMSI trades at $86.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas MMSI's P/E ratio is 22.04. In terms of profitability, ICUI's ROE is +0.01%, compared to MMSI's ROE of +0.09%. Regarding short-term risk, ICUI is less volatile compared to MMSI. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check MMSI's competition here
Envista Holdings Corp (NYSE: NVST)
ICUI vs NVST Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, NVST has a market cap of 4B. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while NVST trades at $25.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas NVST's P/E ratio is 16.85. In terms of profitability, ICUI's ROE is +0.01%, compared to NVST's ROE of +0.04%. Regarding short-term risk, ICUI is less volatile compared to NVST. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check NVST's competition here
Pulse Biosciences, Inc. (NASDAQ: PLSE)
ICUI vs PLSE Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, PLSE has a market cap of 3.8B. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while PLSE trades at $49.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas PLSE's P/E ratio is -46.78. In terms of profitability, ICUI's ROE is +0.01%, compared to PLSE's ROE of -0.94%. Regarding short-term risk, ICUI is less volatile compared to PLSE. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check PLSE's competition here
AtriCure, Inc. (NASDAQ: ATRC)
ICUI vs ATRC Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, ATRC has a market cap of 2.9B. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while ATRC trades at $56.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas ATRC's P/E ratio is 1745.96. In terms of profitability, ICUI's ROE is +0.01%, compared to ATRC's ROE of +0.02%. Regarding short-term risk, ICUI is less volatile compared to ATRC. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check ATRC's competition here
DENTSPLY SIRONA Inc. (NASDAQ: XRAY)
ICUI vs XRAY Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, XRAY has a market cap of 2B. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while XRAY trades at $10.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas XRAY's P/E ratio is 6.87. In terms of profitability, ICUI's ROE is +0.01%, compared to XRAY's ROE of -0.40%. Regarding short-term risk, ICUI is less volatile compared to XRAY. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check XRAY's competition here
LeMaitre Vascular, Inc. (NASDAQ: LMAT)
ICUI vs LMAT Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, LMAT has a market cap of 1.8B. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while LMAT trades at $80.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas LMAT's P/E ratio is 29.69. In terms of profitability, ICUI's ROE is +0.01%, compared to LMAT's ROE of +0.16%. Regarding short-term risk, ICUI is less volatile compared to LMAT. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check LMAT's competition here
BioLife Solutions, Inc. (NASDAQ: BLFS)
ICUI vs BLFS Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, BLFS has a market cap of 1.8B. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while BLFS trades at $36.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas BLFS's P/E ratio is -172.18. In terms of profitability, ICUI's ROE is +0.01%, compared to BLFS's ROE of +0.13%. Regarding short-term risk, ICUI is less volatile compared to BLFS. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check BLFS's competition here
Azenta, Inc. (NASDAQ: AZTA)
ICUI vs AZTA Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, AZTA has a market cap of 1.5B. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while AZTA trades at $33.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas AZTA's P/E ratio is 78.64. In terms of profitability, ICUI's ROE is +0.01%, compared to AZTA's ROE of -0.08%. Regarding short-term risk, ICUI is less volatile compared to AZTA. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check AZTA's competition here
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS)
ICUI vs KMTS Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, KMTS has a market cap of 1.5B. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while KMTS trades at $24.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas KMTS's P/E ratio is -9.50. In terms of profitability, ICUI's ROE is +0.01%, compared to KMTS's ROE of -0.64%. Regarding short-term risk, ICUI is less volatile compared to KMTS. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check KMTS's competition here
STAAR Surgical Company (NASDAQ: STAA)
ICUI vs STAA Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, STAA has a market cap of 1.1B. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while STAA trades at $22.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas STAA's P/E ratio is 39.38. In terms of profitability, ICUI's ROE is +0.01%, compared to STAA's ROE of +0.01%. Regarding short-term risk, ICUI is less volatile compared to STAA. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check STAA's competition here
Atrion Corporation (NASDAQ: ATRI)
ICUI vs ATRI Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, ATRI has a market cap of 809.4M. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while ATRI trades at $459.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas ATRI's P/E ratio is 64.50. In terms of profitability, ICUI's ROE is +0.01%, compared to ATRI's ROE of +0.08%. Regarding short-term risk, ICUI is more volatile compared to ATRI. This indicates higher risk in terms of short-term price fluctuations for ICUI.Check ATRI's competition here
AngioDynamics, Inc. (NASDAQ: ANGO)
ICUI vs ANGO Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, ANGO has a market cap of 648.1M. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while ANGO trades at $15.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas ANGO's P/E ratio is -40.21. In terms of profitability, ICUI's ROE is +0.01%, compared to ANGO's ROE of -0.21%. Regarding short-term risk, ICUI is more volatile compared to ANGO. This indicates higher risk in terms of short-term price fluctuations for ICUI.Check ANGO's competition here
Sanara MedTech Inc. (NASDAQ: SMTI)
ICUI vs SMTI Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, SMTI has a market cap of 322.8M. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while SMTI trades at $35.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas SMTI's P/E ratio is -585.17. In terms of profitability, ICUI's ROE is +0.01%, compared to SMTI's ROE of -4.74%. Regarding short-term risk, ICUI is more volatile compared to SMTI. This indicates higher risk in terms of short-term price fluctuations for ICUI.Check SMTI's competition here
Embecta Corp. (NASDAQ: EMBC)
ICUI vs EMBC Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, EMBC has a market cap of 302M. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while EMBC trades at $5.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas EMBC's P/E ratio is 1.96. In terms of profitability, ICUI's ROE is +0.01%, compared to EMBC's ROE of -0.14%. Regarding short-term risk, ICUI is less volatile compared to EMBC. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check EMBC's competition here
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN)
ICUI vs NNNN Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, NNNN has a market cap of 241.8M. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while NNNN trades at $5.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas NNNN's P/E ratio is 79.62. In terms of profitability, ICUI's ROE is +0.01%, compared to NNNN's ROE of +0.27%. Regarding short-term risk, ICUI is less volatile compared to NNNN. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check NNNN's competition here
OraSure Technologies, Inc. (NASDAQ: OSUR)
ICUI vs OSUR Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, OSUR has a market cap of 238.2M. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while OSUR trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas OSUR's P/E ratio is -5.01. In terms of profitability, ICUI's ROE is +0.01%, compared to OSUR's ROE of -0.15%. Regarding short-term risk, ICUI is less volatile compared to OSUR. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check OSUR's competition here
Utah Medical Products, Inc. (NASDAQ: UTMD)
ICUI vs UTMD Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, UTMD has a market cap of 237.6M. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while UTMD trades at $74.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas UTMD's P/E ratio is 22.08. In terms of profitability, ICUI's ROE is +0.01%, compared to UTMD's ROE of +0.09%. Regarding short-term risk, ICUI is more volatile compared to UTMD. This indicates higher risk in terms of short-term price fluctuations for ICUI.Check UTMD's competition here
Pro-Dex, Inc. (NASDAQ: PDEX)
ICUI vs PDEX Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, PDEX has a market cap of 213.6M. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while PDEX trades at $72.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas PDEX's P/E ratio is 16.20. In terms of profitability, ICUI's ROE is +0.01%, compared to PDEX's ROE of +0.31%. Regarding short-term risk, ICUI is less volatile compared to PDEX. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check PDEX's competition here
KORU Medical Systems, Inc. (NASDAQ: KRMD)
ICUI vs KRMD Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, KRMD has a market cap of 145.1M. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while KRMD trades at $3.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas KRMD's P/E ratio is -79.00. In terms of profitability, ICUI's ROE is +0.01%, compared to KRMD's ROE of -0.11%. Regarding short-term risk, ICUI is less volatile compared to KRMD. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check KRMD's competition here
Stereotaxis, Inc. (AMEX: STXS)
ICUI vs STXS Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, STXS has a market cap of 129.3M. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while STXS trades at $1.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas STXS's P/E ratio is -7.76. In terms of profitability, ICUI's ROE is +0.01%, compared to STXS's ROE of -1.33%. Regarding short-term risk, ICUI is less volatile compared to STXS. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check STXS's competition here
Daxor Corporation (NASDAQ: DXR)
ICUI vs DXR Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, DXR has a market cap of 68M. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while DXR trades at $11.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas DXR's P/E ratio is 9.47. In terms of profitability, ICUI's ROE is +0.01%, compared to DXR's ROE of +0.13%. Regarding short-term risk, ICUI is less volatile compared to DXR. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check DXR's competition here
Akoya Biosciences, Inc. (NASDAQ: AKYA)
ICUI vs AKYA Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, AKYA has a market cap of 64.4M. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while AKYA trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas AKYA's P/E ratio is -1.34. In terms of profitability, ICUI's ROE is +0.01%, compared to AKYA's ROE of -1.80%. Regarding short-term risk, ICUI is more volatile compared to AKYA. This indicates higher risk in terms of short-term price fluctuations for ICUI.Check AKYA's competition here
SkyAI, Inc. (NASDAQ: STSS)
ICUI vs STSS Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, STSS has a market cap of 53.7M. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while STSS trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas STSS's P/E ratio is -0.02. In terms of profitability, ICUI's ROE is +0.01%, compared to STSS's ROE of -1.54%. Regarding short-term risk, ICUI is less volatile compared to STSS. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check STSS's competition here
Singular Genomics Systems, Inc. (NASDAQ: OMIC)
ICUI vs OMIC Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, OMIC has a market cap of 50.8M. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while OMIC trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas OMIC's P/E ratio is -0.58. In terms of profitability, ICUI's ROE is +0.01%, compared to OMIC's ROE of -0.43%. Regarding short-term risk, ICUI is more volatile compared to OMIC. This indicates higher risk in terms of short-term price fluctuations for ICUI.Check OMIC's competition here
GlucoTrack, Inc. (NASDAQ: IGAP)
ICUI vs IGAP Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, IGAP has a market cap of 50.2M. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while IGAP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas IGAP's P/E ratio is -10.52. In terms of profitability, ICUI's ROE is +0.01%, compared to IGAP's ROE of +1.80%. Regarding short-term risk, ICUI is less volatile compared to IGAP. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check IGAP's competition here
Nephros, Inc. (NASDAQ: NEPH)
ICUI vs NEPH Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, NEPH has a market cap of 46.6M. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while NEPH trades at $4.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas NEPH's P/E ratio is 71.50. In terms of profitability, ICUI's ROE is +0.01%, compared to NEPH's ROE of +0.16%. Regarding short-term risk, ICUI is less volatile compared to NEPH. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check NEPH's competition here
Precision Optics Corporation, Inc. (NASDAQ: POCI)
ICUI vs POCI Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, POCI has a market cap of 46.1M. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while POCI trades at $4.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas POCI's P/E ratio is -6.68. In terms of profitability, ICUI's ROE is +0.01%, compared to POCI's ROE of -0.37%. Regarding short-term risk, ICUI is less volatile compared to POCI. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check POCI's competition here
Harvard Bioscience, Inc. (NASDAQ: HBIO)
ICUI vs HBIO Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, HBIO has a market cap of 36M. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while HBIO trades at $8.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas HBIO's P/E ratio is -22.17. In terms of profitability, ICUI's ROE is +0.01%, compared to HBIO's ROE of -0.92%. Regarding short-term risk, ICUI is more volatile compared to HBIO. This indicates higher risk in terms of short-term price fluctuations for ICUI.Check HBIO's competition here
Milestone Scientific Inc. (AMEX: MLSS)
ICUI vs MLSS Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, MLSS has a market cap of 35.5M. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while MLSS trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas MLSS's P/E ratio is -8.02. In terms of profitability, ICUI's ROE is +0.01%, compared to MLSS's ROE of -1.49%. Regarding short-term risk, ICUI is less volatile compared to MLSS. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check MLSS's competition here
SmileDirectClub, Inc. (NASDAQ: SDC)
ICUI vs SDC Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, SDC has a market cap of 29.1M. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while SDC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas SDC's P/E ratio is -0.03. In terms of profitability, ICUI's ROE is +0.01%, compared to SDC's ROE of -1.96%. Regarding short-term risk, ICUI is less volatile compared to SDC. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check SDC's competition here
Invacare Corporation (NYSE: IVC)
ICUI vs IVC Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, IVC has a market cap of 24.9M. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while IVC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas IVC's P/E ratio is -0.79. In terms of profitability, ICUI's ROE is +0.01%, compared to IVC's ROE of -0.46%. Regarding short-term risk, ICUI is less volatile compared to IVC. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check IVC's competition here
Retractable Technologies, Inc. (AMEX: RVP)
ICUI vs RVP Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, RVP has a market cap of 20.4M. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while RVP trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas RVP's P/E ratio is -5.67. In terms of profitability, ICUI's ROE is +0.01%, compared to RVP's ROE of -0.05%. Regarding short-term risk, ICUI is less volatile compared to RVP. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check RVP's competition here
Bionano Genomics, Inc. (NASDAQ: BNGO)
ICUI vs BNGO Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, BNGO has a market cap of 17.9M. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while BNGO trades at $1.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas BNGO's P/E ratio is -0.36. In terms of profitability, ICUI's ROE is +0.01%, compared to BNGO's ROE of -0.79%. Regarding short-term risk, ICUI is less volatile compared to BNGO. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check BNGO's competition here
Jin Medical International Ltd. (NASDAQ: ZJYL)
ICUI vs ZJYL Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, ZJYL has a market cap of 15.6M. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while ZJYL trades at $1.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas ZJYL's P/E ratio is 13.61. In terms of profitability, ICUI's ROE is +0.01%, compared to ZJYL's ROE of +0.04%. Regarding short-term risk, ICUI is less volatile compared to ZJYL. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check ZJYL's competition here
Regentis Biomaterials Ltd. (AMEX: RGNT)
ICUI vs RGNT Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, RGNT has a market cap of 12.6M. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while RGNT trades at $1.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas RGNT's P/E ratio is -0.07. In terms of profitability, ICUI's ROE is +0.01%, compared to RGNT's ROE of N/A. Regarding short-term risk, ICUI is less volatile compared to RGNT. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check RGNT's competition here
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (NASDAQ: CUPR)
ICUI vs CUPR Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, CUPR has a market cap of 7.9M. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while CUPR trades at $1.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas CUPR's P/E ratio is -2.12. In terms of profitability, ICUI's ROE is +0.01%, compared to CUPR's ROE of -15.69%. Regarding short-term risk, ICUI is less volatile compared to CUPR. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check CUPR's competition here
Femasys Inc. (NASDAQ: FEMY)
ICUI vs FEMY Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, FEMY has a market cap of 7.7M. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while FEMY trades at $2.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas FEMY's P/E ratio is -0.57. In terms of profitability, ICUI's ROE is +0.01%, compared to FEMY's ROE of -2.26%. Regarding short-term risk, ICUI is less volatile compared to FEMY. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check FEMY's competition here
Lucyd, Inc (NASDAQ: LUCY)
ICUI vs LUCY Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, LUCY has a market cap of 5.2M. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while LUCY trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas LUCY's P/E ratio is -0.49. In terms of profitability, ICUI's ROE is +0.01%, compared to LUCY's ROE of -0.89%. Regarding short-term risk, ICUI is less volatile compared to LUCY. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check LUCY's competition here
NanoString Technologies, Inc. (NASDAQ: NSTG)
ICUI vs NSTG Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, NSTG has a market cap of 5.1M. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while NSTG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas NSTG's P/E ratio is -0.03. In terms of profitability, ICUI's ROE is +0.01%, compared to NSTG's ROE of -1.43%. Regarding short-term risk, ICUI is less volatile compared to NSTG. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check NSTG's competition here
Predictive Oncology Inc. (NASDAQ: POAI)
ICUI vs POAI Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, POAI has a market cap of 3.6M. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while POAI trades at $4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas POAI's P/E ratio is -0.03. In terms of profitability, ICUI's ROE is +0.01%, compared to POAI's ROE of -21.19%. Regarding short-term risk, ICUI is less volatile compared to POAI. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check POAI's competition here
Meihua International Medical Technologies Co., Ltd. (NASDAQ: MHUA)
ICUI vs MHUA Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, MHUA has a market cap of 2.4M. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while MHUA trades at $7.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas MHUA's P/E ratio is 0.25. In terms of profitability, ICUI's ROE is +0.01%, compared to MHUA's ROE of +0.07%. Regarding short-term risk, ICUI is more volatile compared to MHUA. This indicates higher risk in terms of short-term price fluctuations for ICUI.Check MHUA's competition here
NEXGEL, Inc. (NASDAQ: NXGL)
ICUI vs NXGL Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, NXGL has a market cap of 2.4M. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while NXGL trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas NXGL's P/E ratio is -0.40. In terms of profitability, ICUI's ROE is +0.01%, compared to NXGL's ROE of -1.33%. Regarding short-term risk, ICUI is less volatile compared to NXGL. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check NXGL's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVD)
ICUI vs GMVD Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, GMVD has a market cap of 1.8M. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while GMVD trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas GMVD's P/E ratio is -0.01. In terms of profitability, ICUI's ROE is +0.01%, compared to GMVD's ROE of +2.09%. Regarding short-term risk, ICUI is less volatile compared to GMVD. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check GMVD's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVDW)
ICUI vs GMVDW Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, GMVDW has a market cap of 1.8M. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while GMVDW trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas GMVDW's P/E ratio is N/A. In terms of profitability, ICUI's ROE is +0.01%, compared to GMVDW's ROE of +2.09%. Regarding short-term risk, ICUI is less volatile compared to GMVDW. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check GMVDW's competition here
Avinger, Inc. (NASDAQ: AVGR)
ICUI vs AVGR Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, AVGR has a market cap of 1.5M. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while AVGR trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas AVGR's P/E ratio is -0.05. In terms of profitability, ICUI's ROE is +0.01%, compared to AVGR's ROE of +17.82%. Regarding short-term risk, ICUI is less volatile compared to AVGR. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check AVGR's competition here
NEXGEL, Inc. (NASDAQ: NXGLW)
ICUI vs NXGLW Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, NXGLW has a market cap of 1.2M. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while NXGLW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas NXGLW's P/E ratio is -0.02. In terms of profitability, ICUI's ROE is +0.01%, compared to NXGLW's ROE of -1.33%. Regarding short-term risk, ICUI is less volatile compared to NXGLW. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check NXGLW's competition here
Lucyd, Inc (NASDAQ: LUCYW)
ICUI vs LUCYW Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, LUCYW has a market cap of 296.1K. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while LUCYW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas LUCYW's P/E ratio is N/A. In terms of profitability, ICUI's ROE is +0.01%, compared to LUCYW's ROE of -0.89%. Regarding short-term risk, ICUI is less volatile compared to LUCYW. This indicates lower risk in terms of short-term price fluctuations for ICUI.Check LUCYW's competition here
Hill-Rom Holdings, Inc. (NYSE: HRC)
ICUI vs HRC Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, HRC has a market cap of 0. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while HRC trades at $155.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas HRC's P/E ratio is 41.92. In terms of profitability, ICUI's ROE is +0.01%, compared to HRC's ROE of +0.14%. Regarding short-term risk, ICUI is more volatile compared to HRC. This indicates higher risk in terms of short-term price fluctuations for ICUI.Check HRC's competition here
IntriCon Corporation (NASDAQ: IIN)
ICUI vs IIN Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, IIN has a market cap of 0. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while IIN trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas IIN's P/E ratio is 226.45. In terms of profitability, ICUI's ROE is +0.01%, compared to IIN's ROE of -0.00%. Regarding short-term risk, ICUI is more volatile compared to IIN. This indicates higher risk in terms of short-term price fluctuations for ICUI.Check IIN's competition here
Analogic Corporation (NASDAQ: ALOG)
ICUI vs ALOG Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, ALOG has a market cap of 0. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while ALOG trades at $83.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas ALOG's P/E ratio is 40.93. In terms of profitability, ICUI's ROE is +0.01%, compared to ALOG's ROE of -0.15%. Regarding short-term risk, ICUI is more volatile compared to ALOG. This indicates higher risk in terms of short-term price fluctuations for ICUI.Check ALOG's competition here
Apria, Inc. (NASDAQ: APR)
ICUI vs APR Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, APR has a market cap of 0. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while APR trades at $37.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas APR's P/E ratio is 22.59. In terms of profitability, ICUI's ROE is +0.01%, compared to APR's ROE of +9.81%. Regarding short-term risk, ICUI is more volatile compared to APR. This indicates higher risk in terms of short-term price fluctuations for ICUI.Check APR's competition here
Antares Pharma, Inc. (NASDAQ: ATRS)
ICUI vs ATRS Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, ATRS has a market cap of 0. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while ATRS trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas ATRS's P/E ratio is 14.95. In terms of profitability, ICUI's ROE is +0.01%, compared to ATRS's ROE of +0.31%. Regarding short-term risk, ICUI is more volatile compared to ATRS. This indicates higher risk in terms of short-term price fluctuations for ICUI.Check ATRS's competition here
Invuity, Inc. (NASDAQ: IVTY)
ICUI vs IVTY Comparison September 2026
ICU Medical, Inc. (NASDAQ: ICUI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICUI stands at 3.9B. In comparison, IVTY has a market cap of 0. Regarding current trading prices, ICUI is priced at $158.15 on the NASDAQ, while IVTY trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICUI currently has a P/E ratio of 19.46, whereas IVTY's P/E ratio is -3.80. In terms of profitability, ICUI's ROE is +0.01%, compared to IVTY's ROE of -2.40%. Regarding short-term risk, ICUI is more volatile compared to IVTY. This indicates higher risk in terms of short-term price fluctuations for ICUI.Check IVTY's competition here